According to AIM ImmunoTech 's latest financial reports the company's total assets are $16.18 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $40.48 M | -29.83% |
2021-12-31 | $57.69 M | -10.66% |
2020-12-31 | $64.58 M | 211.19% |
2019-12-31 | $20.75 M | 49.9% |
2018-12-31 | $13.84 M | -2.55% |
2017-12-31 | $14.2 M | -24.72% |
2016-12-31 | $18.87 M | -17.24% |
2015-12-31 | $22.8 M | -22.54% |
2014-12-31 | $29.44 M | -7.62% |
2013-12-31 | $31.86 M | -44.77% |
2012-12-31 | $57.69 M | 32.6% |
2011-12-31 | $43.51 M | -15.8% |
2010-12-31 | $51.68 M | -20.48% |
2009-12-31 | $64.99 M | 391.97% |
2008-12-31 | $13.21 M | -42.91% |
2007-12-31 | $23.14 M | -26.37% |
2006-12-31 | $31.43 M | 27.49% |
2005-12-31 | $24.65 M | -2.53% |
2004-12-31 | $25.29 M | 88.7% |
2003-12-31 | $13.4 M | 121.92% |
2002-12-31 | $6.04 M | -49.81% |
2001-12-31 | $12.03 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $1.97 B | 12,093.59% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $18.17 M | 12.25% | ๐บ๐ธ USA |